134 related articles for article (PubMed ID: 1354747)
1. Labelling of rat brain beta-adrenoceptors: (3H)CGP-12177 or (125I)iodocyanopindolol?
Morin D; Zini R; Urien S; Sapena R; Tillement JP
J Recept Res; 1992; 12(3):369-87. PubMed ID: 1354747
[TBL] [Abstract][Full Text] [Related]
2. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
3. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.
Nanoff C; Freissmuth M; Schütz W
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of bunitrolol for beta 1- and beta 2-adrenergic receptors and 5HT1B-receptors: assessment by biphasic Scatchard plots and biphasic displacement curve analysis with 125I-iodocyanopindolol and 3H-CGP12177.
Tsuchihashi H; Nagotomo T; Imai S
Jpn J Pharmacol; 1989 Jun; 50(2):93-100. PubMed ID: 2570175
[TBL] [Abstract][Full Text] [Related]
6. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
Sillence MN; Moore NG; Pegg GG; Lindsay DB
Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
[TBL] [Abstract][Full Text] [Related]
8. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
9. Three binding sites of 125I-iodocyanopindolol, i.e. beta 1, beta 2-adrenergic and 5HT1B-serotonergic receptors in rat brain determined by the displacement and Scatchard analysis.
Tsuchihashi H; Nagatomo T; Imai S
J Pharmacobiodyn; 1989 Sep; 12(9):509-16. PubMed ID: 2559184
[TBL] [Abstract][Full Text] [Related]
10. Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies.
Bundkirchen A; Brixius K; Bölck B; Nguyen Q; Schwinger RH
Eur J Pharmacol; 2003 Jan; 460(1):19-26. PubMed ID: 12535855
[TBL] [Abstract][Full Text] [Related]
11. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
12. The characterization of beta adrenoceptor subtypes in the rat amygdala and hippocampus.
Tiong AH; Richardson JS
Int J Neurosci; 1990 Oct; 54(3-4):231-44. PubMed ID: 1979972
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptors in the tree shrew brain. I. Distribution and characterization of [125I]iodocyanopindolol binding sites.
Flügge G; Ahrens O; Fuchs E
Cell Mol Neurobiol; 1997 Aug; 17(4):401-15. PubMed ID: 9262867
[TBL] [Abstract][Full Text] [Related]
14. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
Offord SJ; Ordway GA; Frazer A
J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
[TBL] [Abstract][Full Text] [Related]
15. Identification of beta 2-adrenoceptors on guinea pig alveolar macrophages using (-)-3-[125I]iodocyanopindolol.
Leurs R; Beusenberg FD; Bast A; Van Amsterdam JG; Timmerman H
Inflammation; 1990 Aug; 14(4):421-6. PubMed ID: 1974244
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
Matsumoto I; Combs MR; Jones DJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
[TBL] [Abstract][Full Text] [Related]
17. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
Waldmeier PC; Williams M; Baumann PA; Bischoff S; Sills MA; Neale RF
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Sakuma N; Tsuchihashi H; Hosohata Y; Akashi H; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 May; 14(5):250-5. PubMed ID: 1685186
[TBL] [Abstract][Full Text] [Related]
19. Characterization of beta-adrenoceptors responsible for venom production in the venom gland of the snake Bothrops jararaca.
Yamanouye N; Carneiro SM; Scrivano CN; Markus RP
Life Sci; 2000 Jun; 67(3):217-26. PubMed ID: 10983865
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
Port JD; Debellis CC; Klein J; Peeters GA; Barry WH; Bristow MR
J Pharmacol Exp Ther; 1992 Jul; 262(1):217-24. PubMed ID: 1352549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
